跳至主要内容
临床试验/NL-OMON47286
NL-OMON47286尚未招募4 期

Amsterdam Spondyloarthritis cohort (AmSpA cohort) - AmSpA cohort

Vrije Universiteit Medisch Centrum0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • -* diagnosis of axial or peripheral spondyloarthritis, according to the:
  • o the modified New York criteria OR
  • o the ESSG criteria OR
  • o the ASAS classification criteria, including axial as well as peripheral SpA
  • * signed informed consent

排除标准

  • Unable to understand the study aims and methods;Remark: For patients initiating a biological, a treatment selection in daily clinical practice on contra-indications described in the Dutch national guidelines for initiation of a biological treatment, were taken into consideration, especially considering females. An exception is made for treatment with certoluzimab, which can be continued during late gestation and during breastfeeding

研究者

相似试验